U2AF1 and SRSF2 missense mutations are reported in 11% and 12–15% of MDS, respectively [19], and very rarely overlap with SF3B1 mutations, which are present in 17–28% of MDS patients [37,39]. This evidence concerns the gene SF3B1 and myelodysplastic syndrome.